Skip to main content
Log in

Surgical Management of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

  • SSAT other
  • Published:
Journal of Gastrointestinal Surgery

An Erratum to this article was published on 20 June 2008

An Erratum to this article was published on 20 June 2008

Abstract

Intraductal papillary mucinous neoplasm (IPMN) of the pancreas is characterized by papillary growths within the pancreatic ductal system that are at risk for undergoing malignant transformation. Main duct IPMN carries a significant risk of malignancy, and operation is recommended regardless of the presence of symptoms. The risk of malignancy is much lower for side branch IPMN, and current evidence suggests that, in the absence of symptoms, mural nodules, positive cytology, or cyst size less than 3 cm, observation is warranted. When operation is indicated, targeted pancreatic resection with frozen-section analysis of margins is recommended. Pancreatoduodenectomy or distal pacreatectomy is appropriate for the majority. Only in about 10% of patients is the disease so diffuse at presentation that total pancreatectomy is necessary. Survival following pancreatic resection for noninvasive IPMN is excellent. The risk of recurrence following pancreatic resection for invasive IPMN is significant. Surveillance is warranted both for patients subjected to pancreatic resection and for those under observation with side branch IPMN. Much is yet to be learned regarding this neoplasm, and surgical management remains in evolution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Longnecker DS, Adler G, Hruban RH, Kloppel G. Intraductal papillary-mucinous neoplasms of the pancreas. In Hamilton SR, Aaltonen LA, eds: World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. Lyon: IARC Press, 2000, pp 237–241.

    Google Scholar 

  2. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17–31.

    Article  PubMed  Google Scholar 

  3. Brugge WR, Lewandrowski K, Lee-Lewandrowski E. et al. Diagnosis of pancreatic cystic neoplasms: A report of the cooperative pancreatic cyst study. Gastroenterology 2004;126:1330–1336.

    Article  PubMed  Google Scholar 

  4. Pinto MM, Meriano FV. Diagnosis of cystic pancreatic lesions by cytologic examination and carcinoembryonic antigen and amylase assays of cyst contents. Acta Cytol 1991;35:456–463.

    PubMed  CAS  Google Scholar 

  5. Ban S, Naitoh Y, Mino-Kenudson M, et al. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: Its histopathologic difference between 2 major types. Am J Surg 2006;30:1561–1569.

    Article  Google Scholar 

  6. Serikawa M, Sasaki T, Fujimoto Y, et al. Management of intraductal papillary-mucinous neoplasm of the pancreas. Treatment strategy based on morphologic classification. J Clin Gastroenterol 2006;40:856–862.

    Article  PubMed  Google Scholar 

  7. Kobari M, Egawa S, Shibuya K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: Differences in clinical characteristics and surgical management. Arch Surg 1999;134:1131–1136.

    Article  PubMed  CAS  Google Scholar 

  8. Terris B, Ponsot P, Paye F, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000;24:1372–1377.

    Article  PubMed  CAS  Google Scholar 

  9. Doi R, Fujimoto K, Wada M, et al. Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery 2002;132:80–85.

    Article  PubMed  Google Scholar 

  10. Matsumoto T, Aramaki M, Yada K, et al. Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol 2003;36:261–265.

    Article  PubMed  Google Scholar 

  11. Choi BS, Kim TK, Kim AY, et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean J Radiol 2003;4:157–162.

    Article  PubMed  Google Scholar 

  12. Kitagawa Y, Unger TA, Taylor S, et al. Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg 2003;7:12–19.

    Article  PubMed  Google Scholar 

  13. Sugiyama M, Izumisato Y, Abe N, et al. Predictive factors for malignancy in intraductal papillary-mucinous tumors of the pancreas. Br J Surg 2003;90:1244–1249.

    Article  PubMed  CAS  Google Scholar 

  14. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004;239:788–799.

    Article  PubMed  Google Scholar 

  15. Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004;239:678–687.

    Article  PubMed  Google Scholar 

  16. Pelaez-Luna M, Chari ST, Smyrk T, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol 2007;102:1759–1764.

    Article  PubMed  Google Scholar 

  17. Sarr MG, Murr M, Smyrk TC, et al. Primary cystic neoplasms of the pancreas. J Gastrointest Surg 2003;7:417–428.

    Article  PubMed  Google Scholar 

  18. Brugge WR, Lauwers GY, Sahani D, et al. Cystic neoplasms of the pancreas. N Engl J Med 2004;351:1218–1226.

    Article  PubMed  CAS  Google Scholar 

  19. Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002;123:1500–1507.

    Article  PubMed  Google Scholar 

  20. Traverso LW, Peralta EA, Ryan JA, et al. Intraductal neoplasms of the pancreas. Am J Surg 1998;175:426–432.

    Article  PubMed  CAS  Google Scholar 

  21. Cuillerier E, Cellier C, Palazzo L, et al. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol 2000;95:441–445.

    Article  PubMed  CAS  Google Scholar 

  22. Paye R, Sauvanet A, Terris B, et al. Intraductal papillary mucinous tumors of the pancreas. Pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery 2000;127:536–544.

    Article  PubMed  CAS  Google Scholar 

  23. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: An increasingly recognized clinicopathologic entity. Ann Surg 2001;234:313–322.

    Article  PubMed  CAS  Google Scholar 

  24. Billings BJ, Christein JD, Harmsen WS, et al. Quality-of-life after total pancreatectomy: Is it really that bad on long-term follow-up? J Gastrointest Surg 2005;9:1059–1067.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael B. Farnell.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s11605-008-0562-3

Rights and permissions

Reprints and permissions

About this article

Cite this article

Farnell, M.B. Surgical Management of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas. J Gastrointest Surg 12, 414–416 (2008). https://doi.org/10.1007/s11605-007-0349-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-007-0349-y

Keywords

Navigation